Type 2 diabetes and bone fractures
- PMID: 22262002
- PMCID: PMC4753802
- DOI: 10.1097/MED.0b013e328350a6e1
Type 2 diabetes and bone fractures
Abstract
Purpose of review: To discuss current literature and hypotheses pertaining to the pathophysiology of increased bone fragility and fracture in men and women with type 2 diabetes mellitus.
Recent findings: Despite high bone mineral density, studies have shown that men and women with type 2 diabetes mellitus (T2DM) are at increased risk for fracture. Complications of T2DM including retinopathy and autonomic dysfunction may contribute to bone fracture by increasing fall risk. Nephropathy may lead to renal osteodystrophy. Lean mass and potentially fat mass, may additionally contribute to skeletal health in diabetes. There is increasing acknowledgement that the marrow microenvironment is critical to efficient bone remodeling. Medications including thiazolidinediones and selective serotonin reuptake inhibitors may also impair bone remodeling by acting on mesenchymal stem cell differentiation and osteoblastogenesis. T2DM is associated with significant alterations in systemic inflammation, advanced glycation end-product accumulation and reactive oxygen species generation. These systemic changes may also directly and adversely impact the remodeling cycle and lead to bone fragility in T2DM, though more research is needed.
Summary: Fracture is a devastating event with dismal health consequences. Identifying the extrinsic and intrinsic biochemical causes of bone fracture in T2DM will speed the discovery of effective strategies for fracture prevention and treatment in this at-risk population.
Conflict of interest statement
No potential conflicts of interest or financial disclosures relevant to this article were reported.
Figures
References
- 
    - Dawson-Hughes B, Tosteson AN, Melton LJ, 3rd, et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int. 2008;19:449–458. - PubMed
 
- 
    - Looker AC, Dawson-Hughes B, Tosteson AN, et al. Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance. Osteoporos Int. 2010;22:541–549. Updated guidelines based on the National Health and Nutrition Examination Survey II data demonstrating that men and women eligible for osteoporosis treatment are five times more likely to experience hip fracture. - PubMed
 
- 
    - Leibson CL, Tosteson AN, Gabriel SE, et al. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc. 2002;50:1644–1650. - PubMed
 
- 
    - Tosteson AN, Gabriel SE, Grove MR, et al. Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporos Int. 2001;12:1042–1049. - PubMed
 
- 
    - Arinzon Z, Fidelman Z, Zuta A, et al. Functional recovery after hip fracture in old-old elderly patients. Arch Gerontol Geriatr. 2005;40:327–336. - PubMed
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
- Full Text Sources
- Medical
- Research Materials
 
         
              